Evidence map›Paper›PMID 37483119›Full record

ArticlePsychogeriatrics : the official journal of the Japanese Psychogeriatric Society2023

Analysis of factors related to cognitive impairment in a community-based, complete enumeration survey in Japan: the Nakayama study.

Taku Yoshida, Takaaki Mori, Hideaki Shimizu, Ayumi Tachibana, Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Yuki Ozaki, Kentaro Kawabe, Fumie Horiuchi and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Taku YoshidaDepartment of Psychiatry, Zaidan Niihama Hospital, Niihama, Japan.
Takaaki MoriDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Hideaki ShimizuDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.ORCID https://orcid.org/0000-0003-1402-8015
Ayumi TachibanaDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Yuta YoshinoDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Shinichiro OchiDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Kiyohiro YamazakiDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Yuki OzakiDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Kentaro KawabeDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Fumie HoriuchiDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Kenjiro KomoriDepartment of Psychiatry, Zaidan Niihama Hospital, Niihama, Japan.
Jun-Ichi IgaDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.ORCID https://orcid.org/0000-0003-4409-3096
Shu-Ichi UenoDepartment of Neuropsychiatry, Ehime University Graduate School of Medicine, Toon, Japan.
Ehime University · JPKobe Kaisei Hospital · JPNational Institute of Technology, Niihama College · JPShikoku (Japan) · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP16-20dk0207025Japan Agency for Medical Research and Development (AMED) JP21dk0207053Suntory Holdings Limited (Osaka, Japan)
6 · The paper itself

Abstract

backgroundThe number of patients with cognitive disorders is rapidly increasing in the world, becoming not only a medical problem, but also a social problem. There have been many reports that various factors are associated with cognitive dysfunction, but the factors have not yet been fully identified. This was a community-based complete enumeration study which aimed to identify risk and protective factors for dementia.

methodsThe first phase included all residents aged 65 years or older in a town in Japan. They completed many examinations, such as living conditions questionnaires, physical examination, Mini-Mental State Examination, and brain magnetic resonance imaging. The participants with suspected cognitive impairment underwent additional examinations for detailed evaluation in the second phase. Statistical analysis was performed to identify risk and protective factors for dementia after all participants were diagnosed.

resultsThere were 927 participants in the baseline evaluation; 611 (65.9%) were healthy, 165 (17.8%) had mild cognitive impairment (MCI), and 151 (16.3%) had dementia. The age-standardised prevalence of dementia was 9.5%. Statistical analyses for amnestic MCI and Alzheimer's disease showed that risk factors for cognitive decline were diabetes mellitus, low activities of daily living, and living alone, and that protective factors were history of exercise and drinking habit.

conclusionThe present findings suggest that several lifestyle-related diseases and factors are associated with cognitive decline. These results support similar findings from previous studies and will be helpful for preventing dementia in the future.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDementiaActivities of Daily LivingHumansJapanSurveys and QuestionnairesAlzheimer's diseasecognitive impairment's factorscomplete enumeration surveydiabetes mellitus

Identifiers

PMID37483119
PMCPMC11578018
OpenAlexW4385144402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.